Scott Wapner and the Investment Committee debate the post-election surge and how long it might last. Plus, Jim Lebenthal buying more of one pharma stock getting slammed today, he reveals why. And later, the desk gives you the setup on earnings this week.
Investment Committee Disclosures
Mar 2025
Stocks Wrap Up Volatile Week… And Dissecting The Tech Wreck 3/7/25
<p>Stocks bouncing back Friday after a very volatile week. The S&P posting its worst week since September as a weak jobs report, Fed comments, and more tariff headlines rock markets. So will the volatility continue? And A take on Tech, as Meta erases nearly all of its record rall ... Show More
43m 45s
Apr 2025
Markets rip higher on tariff hopes… and earnings roll in 4/23/25
<p>Stocks surge on renewed trade optimism and dovish tones out of Washington. Plus big earnings movers: Southwest, Chipotle, IBM, and Texas Instrument. And CME Group CEO Terry Duffy joins us to break down market volatility and clear up confusion over their results</p><p> </p><p>< ... Show More
43m 5s
Sep 27
What’s News in Markets: CarMax Woes, Intel Soars, Tylenol Pressure
Why did CarMax’s earnings spook investors? And how has Intel stock gained 46% this month? Plus, what’s driving a sharp selloff in Kenvue shares? Host Jack Pitcher discusses the biggest stock moves of the week and the news that drove them. Sign up for the WSJ's free Markets A.M. n ... Show More
5m 11s